Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice
- 1 September 2019
- journal article
- conference paper
- Published by Elsevier in Journal of Controlled Release
- Vol. 310, 188-197
Abstract
No abstract availableKeywords
Funding Information
- General Research Fund (17120915, 17146216, 17100317)
- National Natural Science Foundation of China (81703726, 21778046)
- Health and Medical Research Fund (15161731, 16171751)
- Science, Technology and Innovation Commission of Shenzhen Municipality (16636)
- Seed Funding (201611159156)
This publication has 39 references indexed in Scilit:
- Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent MannerCell Metabolism, 2016
- In Vivo Cardioprotective Effects and Pharmacokinetic Profile of N-Propyl Caffeamide Against Ischemia Reperfusion InjuryArchivum Immunologiae et Therapiae Experimentalis, 2016
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to DatePharmaceutical Research, 2016
- Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional AxisCell Metabolism, 2015
- Treatment of Obesity with CelastrolCell, 2015
- Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolismEuropean Journal of Pharmacology, 2014
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetesDiabetes Research and Clinical Practice, 2014
- Celastrol: Molecular targets of Thunder God VineBiochemical and Biophysical Research Communications, 2010
- Prevalence and Trends in Obesity Among US Adults, 1999-2008JAMA, 2010
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin ResistanceCell Metabolism, 2008